Literature DB >> 6481285

Effect of parathyroid hormone and calcitonin on the cytoplasmic spreading of isolated osteoclasts.

T J Chambers, N A Athanasou, K Fuller.   

Abstract

Osteoclasts, the major agents of bone resorption, were isolated from neonatal rat bone, and the cytoplasmic spreading of these cells was measured after incubation in the presence or absence of hormones or other cell types. Salmon calcitonin, which inhibits osteoclastic bone resorption, reduced spreading in a dose-dependent manner and caused significant inhibition at concentrations as low as 6.7 pg/ml. Parathyroid hormone (PTH) had no effect on the spreading of isolated osteoclasts but if osteoblasts and osteoclasts were co-cultured the addition of PTH caused a marked increase in spreading at concentrations of 0.025 i.u./ml and above. The results suggest that while calcitonin is a direct inhibitor of osteoclastic activity, PTH may stimulate osteoclasts through a primary action on osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6481285     DOI: 10.1677/joe.0.1020281

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  11 in total

1.  A quantitative cytochemical investigation of osteoclasts and multinucleate giant cells.

Authors:  M H Zheng; J M Papadimitriou; G C Nicholson
Journal:  Histochem J       Date:  1991-04

Review 2.  The pathobiology of the osteoclast.

Authors:  T J Chambers
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

3.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

Authors:  G C Nicholson; J M Moseley; P M Sexton; F A Mendelsohn; T J Martin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  Induction of ornithine decarboxylase activity in isolated chicken osteoblasts by parathyroid hormone: the role of cAMP and calcium.

Authors:  C W Löwik; A A Olthof; J P van Leeuwen; J K van Zeeland; M P Herrmann-Erlee
Journal:  Calcif Tissue Int       Date:  1988-07       Impact factor: 4.333

5.  Calcitonin gene-related peptide inhibits osteoclastic bone resorption: a comparative study.

Authors:  M Zaidi; K Fuller; P J Bevis; R E GainesDas; T J Chambers; I MacIntyre
Journal:  Calcif Tissue Int       Date:  1987-03       Impact factor: 4.333

6.  Hormone-stimulated modulation of endocytic trafficking in osteoclasts.

Authors:  Gudrun Stenbeck; Kevin M Lawrence; Anthony P Albert
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-22       Impact factor: 5.555

Review 7.  Molecular regulation of osteoclast activity.

Authors:  Angela Bruzzaniti; Roland Baron
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

8.  Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts.

Authors:  T Kameda; H Mano; T Yuasa; Y Mori; K Miyazawa; M Shiokawa; Y Nakamaru; E Hiroi; K Hiura; A Kameda; N N Yang; Y Hakeda; M Kumegawa
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

9.  TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

Authors:  K Fuller; B Wong; S Fox; Y Choi; T J Chambers
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

10.  Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.

Authors:  Yi-Jie Kuo; Fon-Yih Tsuang; Jui-Sheng Sun; Chi-Hung Lin; Chia-Hsien Chen; Jia-Ying Li; Yi-Chian Huang; Wei-Yu Chen; Chin-Bin Yeh; Jia-Fwu Shyu
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.